From the 2014 IMWG Conference Series Debate:

56th ASH Annual Meeting
December 8, 2014
San Francisco, CA, USA

Previous Post
NLB 2014: Case Studies: Relapsed Refractory Myeloma, Adherence, Clonal Evolution, Emerging Therapies
Next Post
What is the 17p deletion?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.